524606 — Beryl Drugs Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Beryl Drugs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	6.58	12.2	15.6	6.61	9.43
Net Total Accounts Receivable
Net Total Receivables	46.5	45.8	69.2	75.8	54.6
Total Inventory
Total Other Current Assets
Total Current Assets	102	106	103	102	90.4
Net Property, Plant And Equipment	73.2	58.6	58.1	59.6	60
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	186	178	175	175	160
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	82.1	84.9	63.3	57.6	43
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	107	105	94.5	85.6	64.6
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	79.3	72.9	80.7	89.2	95
Total Liabilities & Shareholders' Equity	186	178	175	175	160
Total Common Shares Outstanding